Physician profile
Mohit Gupta
NPI 1851522627
$1,041.15
in general payments reported to CMS, 2019-2025
21 companies · $63.29 in 2025
The $63.29 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $49.32 · 2021: $321 · 2022: $141 · 2023: $186 · 2024: $107 · 2025: $63.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $129.93 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $114.62 | 2019-2025 | Trulicity |
| Astrazeneca Pharmaceuticals LP | $98.05 | 2019-2021 | |
| Abbvie INC. | $80.38 | 2021-2023 | |
| Nestle Healthcare Nutrition INC. | $75.58 | 2021-2023 | |
| Amarin Pharma, INC. | $73.84 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $70.64 | 2021-2023 | Ingrezza |
| Merck Sharp & Dohme LLC | $61.95 | 2019-2022 | |
| Pfizer INC. | $55.80 | 2019-2024 | |
| Lundbeck LLC | $49.51 | 2024 | Rexulti |
| Exact Sciences Corporation | $32.44 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $31.81 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.30 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $21.19 | 2024 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.92 | 2025 | Jascayd |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.77 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.37 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $18.12 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.38 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.16 | 2019 | |
| Sanofi Pasteur INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.